Funded Local Who is raising money in your own backyard?

OneMove Technologies Inc. ("OneMove" or the "Company") (TSX-V: OM), a provider of a leading web-based real estate transaction platform, announced today that its previously announced non-brokered private placement was fully subscribed and closed on September 4, 2008.

September 2, 2008 - Burnaby, BC, Canada - International Water-Guard Industries Inc. (IWG) has closed a private placement of $500,000, President & Chief Executive Officer David C. Fox announced.

Victoria, B.C., August 11, 2008 - CardioComm Solutions, Inc. (TSX-V: EKG) ("CardioComm" or the "Company") today announced that it has closed its previously announced non-brokered private placement equity financing. Under the financing, the Company issued 3,500,000 units at a price of $0.10 per unit, with each unit comprising one common share of the Company and one common share purchase warrant exercisable for an additional share at a price of $0.20. The Company realized gross proceeds of $350,000 from the financing, which will be used for general working capital of the Company.

Vancouver, July 30, 2008 - IP Applications Corp. (TSX-V: IPX) (the “Company”) is pleased to announce that further to the Company’s news release of June 20, 2008, it has received final acceptance from the TSX Venture Exchange and formally closed its non-brokered private placement of 3,875,000 Units, at a price of $0.20 per Unit, raising gross proceeds of $775,000. Each Unit consisted of one common share and one-half common share purchase warrant.

Inflazyme Pharmaceuticals Ltd. (NEX:IZP.H) announced today that it has closed in escrow a $300,000 non-brokered unit private placement (the "Offering") for 15,000,000 (3,750,000 post-consolidation) Units (the "Units"). Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Victoria, B.C., June 26, 2008 – CardioComm Solutions, Inc. (TSX-V: EKG) (“CardioComm” or the “Company”) today announced that it will be conducting a non-brokered private placement equity financing under which it will issue 3,500,000 units at a price of $0.10 per unit for gross proceeds of $350,000. The proceeds are intended to replace the funds that were expected to be received by the Company under the fourth and final tranche of the Company’s previously announced convertible note financing, which fourth tranche will not be completed.

VANCOUVER, June 26 - OneMove Technologies Inc. ("OneMove" or the "Company") (TSX-V: OM), a provider of a leading web-based real estate transaction platform, today announces plans to conduct a non-brokered private placement for total proceeds of up to $400,000.

Vancouver, BC (June 16th, 2008) – Chemokine Therapeutics Corp. (the “Company”) (TSX:CTI, OTCBB:CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced that it has closed, via a non-brokered private placement, an offering of approximately 5,900,000 units at a price of $0.15 per unit for gross proceeds to the Company of approximately $885,000 (the “Offering”).

NORTH VANCOUVER, BRITISH COLUMBIA - June 4, 2008) - Open EC Technologies, Inc. ("Open EC" or the "Company") (TSX VENTURE:OCE) is pleased to announce that it has received TSX Venture Exchange approval and has closed its non-brokered private placement with insiders of the Company of 1,166,667 units priced at $0.15 per unit for gross proceeds of $175,000. Each unit consists of one common share of the Company and one share purchase warrant.

Vancouver, B.C.-EnWave Corporation (TSX-V: ENW) (“EnWave”, or the "Company") wishes to announce that it has agreed to a non-brokered private placement of up to 2,750,000 units at a price of $0.30 per unit. Each unit will consist of one common share and one half share purchase warrant. Each whole warrant will entitle the holder to purchase one common share at an exercise price of $0.45 per share for a period of two years from the time of issuance of the units.